BioSpace News Archive

Bcureful and the Tuberous Sclerosis Alliance announced plans to formally combine efforts, specifically by establishing the Bcureful Travel Fund at the TS Alliance.

TAILORx Study Featured in William L. McGuire Memorial Lecture Award at 2019 San Antonio Breast Cancer Symposium®

First New Osteoporosis Medicine Approved in the European Union (EU) Since 2010

Data Expected to be Submitted to U.S. Food and Drug Administration and to the European Medicines Agency in the Near Term

In the latest version of Ortoma Treatment Solution, OTS 4, Ortoma has introduced support of Artificial Intelligence.

HemoCue AB report fruitful discussions, continued support and new activities related to health initiatives, following the participation at the High-Level Business Delegation in New Delhi and Mumbai, on December 2-4, 2019

Bioncotech Therapeutics, a clinical-stage biopharmaceutical company developing RNA-based therapies against cancer, announces the detailed results of its Phase I clinical trial of BO-112 in combination with anti-PD-1 inhibitor in patients with anti-PD refractory cancer, will be presented at the ESMO Immuno-Oncology Congress 2019, 11-14 December 2019, Geneva, Switzerland.

Health Care Originals, a leading digital health tech and wearable devices company that provides the only patch-type ambulatory cough monitor in the world, is pleased to announce a collaboration with Dr. Laurie Slovarp, of the University of Montana, who is pioneering a solution for people plagued with chronic cough.